Collegium Pharmaceutical Inc buy melinda
Start price
01.11.17
/
50%
€9.38
Target price
09.11.17
€10.37
Performance (%)
12.60%
End price
09.11.17
€10.56
Summary
This prediction ended on 09.11.17 with a price of €10.56. The BUY prediction by melinda finished with a performance of 12.60%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Collegium Pharmaceutical Inc | 6.944% | 6.944% | 54.000% | 46.667% |
| iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
| iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
| iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
| iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by melinda for this prediction
In the thread Collegium Pharmaceutical Inc diskutieren
Xtampza ER (Oxycodon) Starke Schmerzen
Submission ADND angekündigt 5. Oktober 2016, so dass ein PDUFA Datum 4. August 2017 - dreimonatige Verlängerung festgestellt - neues Datum PDUFA etwa 4. November 2017.
Stopped prediction by melinda for Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
Start price
Target price
Perf. (%)
€19.40
28.11.19
28.11.19
-
04.11.21
04.11.21
-14.95%
05.11.21
05.11.21
Collegium Pharmaceutical Inc
Start price
Target price
Perf. (%)
€6.99
09.05.17
09.05.17
€9.29
15.05.17
15.05.17
20.13%
15.05.17
15.05.17
Collegium Pharmaceutical Inc
Start price
Target price
Perf. (%)
€8.68
06.04.17
06.04.17
€17.14
24.04.17
24.04.17
4.05%
24.04.17
24.04.17